Traceability of oncohematological drugs through data capture codes

Traceability of oncohematological drugs through data capture codes

Bibliographic Details
Main Authors:	Amelia Sánchez-Guerrero, Elena García-Sanz, Marta Manso-Manrique, Belén Escudero-Vilaplana
Format:	Article
Language:	English
Published:	Grupo Aula Médica 2017-09-01
Series:	Farmacia Hospitalaria
Online Access:	http://www.aulamedica.es/fh/pdf/10822.pdf

Similar Items

Hypomethylating Agents in Oncohematology
by: AD Shirin,, et al.
Published: (2016-10-01)

Supporting requirement analysis through requirement rationale capture and traceability
by: Dai, Weili
Published: (2014)

Oncohematologic diseases and rheumatic disorders
by: Nelson Hamerschlak
Published: (2008-03-01)

Adverse Reactions to Drugs of Special Interest in a Pediatric Oncohematology Service
by: Kristopher Amaro-Hosey, et al.
Published: (2021-05-01)

INVASIVE ASPERGILLOSIS AND MUCORMYCOSIS IN ONCOHEMATOLOGICAL PATIENTS
by: O. V. Shadrivova, et al.
Published: (2018-07-01)

Characteristics of HCV infection in oncohematological patients
by: D. A. Lioznov, et al.
Published: (2020-03-01)

Missions and potentialities of municipal oncohematological service
by: V V Ptushkin
Published: (2016-12-01)

CHARACTERISTIC OF CATHETERS AND OF CHILDREN WITH ONCOHEMATOLOGICAL DISEASE
by: Liziane Barros Linares Machado, et al.
Published: (2017-03-01)

Biosensors in Clinical Practice: Focus on Oncohematology
by: Agostino Cortelezzi, et al.
Published: (2013-05-01)

Identification of platelet refractoriness in oncohematologic patients
by: Aline Aparecida Ferreira, et al.
Published: (2011-01-01)

Trends in the treatment of cytomegalovirus infection in oncohematological patients
by: D. N. Balashov
Published: (2014-07-01)

MUCORMYCOSIS IN ONCOHEMATOLOGY PATIENTS (results of the prospective study)
by: N. N. Klimko, et al.
Published: (2017-06-01)

COMBINATION OF INVASIVE ASPERGILLOSIS AND MUCORMYCOSIS IN ONCOHEMATOLOGICAL PATIENTS
by: O. V. Shadrivova, et al.
Published: (2018-02-01)

Accompanying therapy in oncohematological patients with secondary immunodeficiency
by: Lali G. Babicheva, et al.
Published: (2020-07-01)

Survey of oncohematological pharmaceutical care situation in Spain
by: María José Martínez-Bautista, et al.
Published: (2019-11-01)

Trends in the treatment of cytomegalovirus infection in oncohematological patients
by: D. N. Balashov
Published: (2014-07-01)

HOSPITALIZATION ONCOHEMATOLOGICAL CLIENT SUBSIDIES FOR NURSING CARE
by: Renata Miranda Sousa, et al.
Published: (2012-08-01)

Towards Understanding the Pathogenicity of DROSHA Mutations in Oncohematology
by: Dmitrii S. Bug, et al.
Published: (2021-09-01)

HOSPITALIZATION ONCOHEMATOLOGICAL CLIENT SUBSIDIES FOR NURSING CARE
by: Renata Miranda Sousa, et al.
Published: (2012-08-01)

HOSPITALIZATION ONCOHEMATOLOGICAL CLIENT SUBSIDIES FOR NURSING CARE
by: Renata Miranda Sousa, et al.
Published: (2012-08-01)

HOSPITALIZATION ONCOHEMATOLOGICAL CLIENT SUBSIDIES FOR NURSING CARE
by: Renata Miranda Sousa, et al.
Published: (2012-08-01)

Multicriteria analysis of the assortment of innovative drugs in oncohematology as a tool for supporting decision-making in the field of drug provision
by: S. V. Nedogoda, et al.
Published: (2018-07-01)

Analysis of the -398C/T polymorphism in the perforin gene in oncohematological patients
by: Fernanda Bernadelli Garcia, et al.
Published: (2011-01-01)

Automated Recovery and Visualization of Test-to-Code Traceability (TCT) Links: An Evaluation
by: Nadera Aljawabrah, et al.
Published: (2021-01-01)

Remodeling of the common carotid artery in oncohematological pathology by ultrasound
by: V. D. Koptev, et al.
Published: (2018-12-01)

NEXT-GENERATION GENE SEQUENCING AND ITS APPLICATIONS IN ONCOHEMATOLOGY
by: I. M. Barkhatov, et al.
Published: (2017-01-01)

RATIONAL PHARMACEUTICAL MANAGEMENT IN PRACTICE OF CHILDREN’S ONCOHEMATOLOGICAL DIVISION
by: Z.A. Maevskaya, et al.
Published: (2010-05-01)

Altered balance between proteolysis and antiproteolysis in oncohematologic diseases
by: O. E. Shaul’ska, et al.
Published: (2015-03-01)

Myeloid-Derived Suppressor Cells in Some Oncohematological Diseases
by: AV Ponomarev
Published: (2017-01-01)

Hepatitis B and C Virus in Children with Oncohematologic Diseases
by: S.A. Kramarev, et al.
Published: (2016-02-01)

Nutrition in the pediatric patient suffering from oncohematological diseases
by: Ana Guillén Mercedes Cánovas, et al.
Published: (2018-10-01)

Emotional State and Coping Strategies of Adolescents with Oncohematological Diseases
by: Khain A.E., et al.
Published: (2018-12-01)

Clinical Significance of the PRAME Gene Expression in Oncohematological Diseases
by: VA Misyurin
Published: (2018-01-01)

Pilot Study on the Cost of Some Oncohematology Diseases in Bulgaria
by: Konstantin Tachkov, et al.
Published: (2019-03-01)

RATIONAL PHARMACEUTICAL MANAGEMENT IN PRACTICE OF CHILDREN’S ONCOHEMATOLOGICAL DIVISION
by: Z.A. Maevskaya, et al.
Published: (2010-05-01)

Finding evidences on oncohematological patients (1st part): Mucositis, pain and satisfaction
by: Josefa Solano Antolinos, et al.
Published: (2008-11-01)

Nutritional intervention in oncohematological patient Intervención nutricional en el paciente oncohematológico
by: C. Gómez-Candela, et al.
Published: (2012-06-01)

Kidney involvement in monoclonal gammopathies: multidisciplinary approach in oncohematology and nephrology
by: A. V. Smirnov, et al.
Published: (2020-07-01)

Features of management of oncohematological patients in the context of the COVID-19 pandemic
by: I. V. Poddubnaya, et al.
Published: (2020-11-01)

Cardiovascular complications of polychemotherapy of oncohematological diseases: Modern approaches to diagnostics
by: B. B. Samura
Published: (2012-12-01)